Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.
about
Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium VivaxMerozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaPaths to a malaria vaccine illuminated by parasite genomicsImmune Escape Strategies of Malaria ParasitesConformational dynamics and antigenicity in the disordered malaria antigen merozoite surface protein 2Plasmodium vivax Reticulocyte Binding Proteins Are Key Targets of Naturally Acquired Immunity in Young Papua New Guinean ChildrenImmunity as a predictor of anti-malarial treatment failure: a systematic reviewDissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.Research priorities for the development and implementation of serological tools for malaria surveillance.Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of responseThe hunt for protective correlates of immunity to Plasmodium falciparum malaria.Mechanisms of stage-transcending protection following immunization of mice with late liver stage-arresting genetically attenuated malaria parasites.The impact of lipid-based nutrient supplementation on anti-malarial antibodies in pregnant women in a randomized controlled trial.Malaria preventive therapy in pregnancy and its potential impact on immunity to malaria in an area of declining transmissionCD14(hi)CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do soNovel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communitiesBreadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infectionAntibody-Dependent Cellular Inhibition Is Associated With Reduced Risk Against Febrile Malaria in a Longitudinal Cohort Study Involving Ghanaian ChildrenStandardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malariaPlasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in KenyaDynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity.Vaccine candidate discovery for the next generation of malaria vaccines.Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth CohortStrain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2.Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.Progress and prospects for blood-stage malaria vaccinesMerozoite Antigens of Plasmodium falciparum Elicit Strain-Transcending Opsonizing Immunity.Relationship between Antibody Levels, IgG Binding to Plasmodium falciparum-Infected Erythrocytes, and Disease Outcome in Hospitalized Urban Malaria Patients from Dakar, Sénégal.Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in ChildrenSkin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunityAssociation between malaria immunity and pregnancy outcomes among Malawian pregnant women receiving nutrient supplementation.Dichotomous miR expression and immune responses following primary blood-stage malaria.The GMZ2 malaria vaccine: from concept to efficacy in humans.The immunological balance between host and parasite in malaria.Blood-stage malaria vaccines: post-genome strategies for the identification of novel vaccine candidates.Immunity to malaria in an era of declining malaria transmission.The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificityHost immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort.Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance.
P2860
Q24273364-5ECE856A-7F46-4AF6-A0DD-21F6C255E457Q26772878-2C68187F-191A-463A-9974-1BE1CA673EC2Q26853267-52EB8D9E-3ABB-4617-8C9D-677431F48A1AQ28072043-642F38E2-7AD6-49D5-97B2-033CD1BFAE6CQ28543881-3DED489E-3BAD-4B71-BC5E-0B5BD2DC1B06Q28554358-77BAF4CF-6E89-427F-895B-D462B8A3AAF5Q33582154-D2A812E9-136D-4DB5-ACB2-23B4D8DBA543Q33851717-6B259C08-44AB-4D28-954D-458352B570E0Q34416904-1506522C-CA54-43A5-981B-DBA6697A4159Q34500035-AC935286-6D7C-42B5-BA52-ADED3376FAB8Q34955461-42812DB4-5D57-4E8D-B437-99FF0BC74A73Q35304594-FABF33C3-7479-4125-92DA-DD08CDFA01A5Q35606514-16B7C084-4764-47FD-829E-E85C540CB272Q35627041-374C12CC-B04E-41BC-BA48-A0F8CFF5A139Q35666958-B2F68E43-544F-435C-A1CA-83D65DAABD17Q35684739-703E7B14-04D1-4E25-BE39-C1AD4CF803EDQ35961275-7FB29EA1-3456-455B-AE9A-45CD8837459DQ36004060-17464DC5-1805-4A64-AE6A-D3983E5527A5Q36051947-917DC8ED-66F9-4194-8748-EB5B93B3C857Q36064542-DF1A6448-3E59-449E-B262-3BCC16D23655Q36148976-36900DF2-6389-419A-9650-1D59883D2322Q36381444-7E231C4A-6F1F-4D94-9805-5A0603119946Q36413834-F4A65D08-0804-4A87-9A82-7D58435B5231Q36555103-E68C22DF-91AA-4D68-A5DD-40EF9F2CA8B1Q36569534-1D07D132-0FC4-4FBE-A8A5-95F805C1DBD5Q36728063-E1AB5117-27BA-4336-AF39-0F59FD1BAB83Q37025030-01C1F64A-2E3B-46B3-8C9B-B61382C2A5FEQ37129892-A0B7D0B2-C613-42A1-8571-51DE5558D632Q37181011-73E89763-66D3-46E1-92D9-D320ED8F8BEBQ37220749-9A495AF2-B49C-4DB3-A5E5-82A1EF023C80Q37254129-9351B73D-2679-441E-98C6-E45A59BA89E6Q37406034-2B9DAB8D-13EC-437C-BADE-BF3BE80E66D1Q38645943-3E67F31B-9DF9-4F64-808C-082370A5AE2BQ38658724-F79D1B91-4A65-4DB8-A8F2-622F471CB71DQ38666558-DB993D8D-A3D7-4D79-84E4-9FFC2ADFC75AQ38672088-E8CAE90A-159C-4F35-B7FB-F423D5CD1F5EQ38689264-DAA002D2-5990-4AE2-850C-7E56B32B197AQ38767298-45486ABB-2916-428B-B656-10D00317C312Q38882700-FE9CE8EB-1C85-415E-84E3-0145AE5319D9Q39230991-831EC71D-04F2-4266-B9E0-2C452A7844A1
P2860
Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Opsonic phagocytosis of Plasmo ...... of protection against malaria.
@ast
Opsonic phagocytosis of Plasmo ...... of protection against malaria.
@en
type
label
Opsonic phagocytosis of Plasmo ...... of protection against malaria.
@ast
Opsonic phagocytosis of Plasmo ...... of protection against malaria.
@en
prefLabel
Opsonic phagocytosis of Plasmo ...... of protection against malaria.
@ast
Opsonic phagocytosis of Plasmo ...... of protection against malaria.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Opsonic phagocytosis of Plasmo ...... of protection against malaria.
@en
P2093
Anthony Jaworowski
Christine Langer
Faith Ha Osier
Fiona J McCallum
Gaoqian Feng
Jingling Zhou
Linda Reiling
P2860
P2888
P356
10.1186/1741-7015-12-108
P407
P577
2014-07-01T00:00:00Z
P5875
P6179
1026086415